NCT03760835View on ClinicalTrials.gov

Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 11, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Congenital Adrenal Hyperplasia
Interventions
DRUG

Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)

Treatment of congenital adrenal hyperplasia

DRUG

Dual release hydrocortisone (plenadren)

Treatment of congenital adrenal hyperplasia

Trial Locations (1)

80131

RECRUITING

Federico II University, Naples

All Listed Sponsors
lead

Federico II University

OTHER